logo

Kymera Therapeutics Inc (KYMR) Stock: Navigating Market Highs and Lows in 52 Weeks

SLGG

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Kymera Therapeutics Inc’s current trading price is -22.49% away from its 52-week high, while its distance from the 52-week low is 265.83%. The stock’s price range during this period has varied between $9.60 and $45.31. The company, active in the Healthcare sector, saw a trading volume of around 0.62 million for the day, considerably lower average daily volume of 0.67 million observed over the last three months.

Kymera Therapeutics Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $45.31 on 02/27/24, and the lowest price during the same period was recorded at $9.60 on 11/02/23.

How Financial Performance Impacts Market Capitalization

Kymera Therapeutics Inc (KYMR) has experienced a quarterly rise of 29.12% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.15B and boasts a workforce of 187 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 32.71, with a change in price of +15.38. Similarly, Kymera Therapeutics Inc recorded 801,598 in trading volume during the last 100 days, posting a change of +77.91%.

How KYMR’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for KYMR stands at 0.21. Similarly, the long-term debt-to-equity ratio is also 0.20.

KYMR Stock Stochastic Average

As of today, the raw stochastic average of Kymera Therapeutics Inc over the past 50 days is 16.06%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 22.36%. Additionally, the Stochastic %K and %D values for the company were 11.11% and 7.24%, respectively, over the past 20 days.

KYMR Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 37.94%.However, over the last six months, we can see a weaker performance of 192.42%. Over the last 30 days, the price of KYMR has leaped by -11.25%. And in the last five days, it has fallen by -5.62%.